Improving the quality of cognitive screening assessments : ACEmobile, an iPad-based version of the Addenbrooke's Cognitive Examination-III
MetadataShow full item record
Introduction: Ensuring reliable administration and reporting of cognitive screening tests are fundamental in establishing good clinical practice and research. This study captured the rate and type of errors in clinical practice, using the Addenbrooke's Cognitive Examination-III (ACE-III), and then the reduction in error rate using a computerized alternative, the ACEmobile app. Methods: In study 1, we evaluated ACE-III assessments completed in National Health Service (NHS) clinics (n = 87) for administrator error. In study 2, ACEmobile and ACE-III were then evaluated for their ability to capture accurate measurement. Results: In study 1, 78% of clinically administered ACE-IIIs were either scored incorrectly or had arithmetical errors. In study 2, error rates seen in the ACE-III were reduced by 85%–93% using ACEmobile. Discussion: Error rates are ubiquitous in routine clinical use of cognitive screening tests and the ACE-III. ACEmobile provides a framework for supporting reduced administration, scoring, and arithmetical error during cognitive screening.
Newman , C G J , Bevins , A D , Zajicek , J P , Hodges , J R , Vuillermoz , E , Dickenson , J M , Kelly , D S , Brown , S & Noad , R F 2018 , ' Improving the quality of cognitive screening assessments : ACEmobile, an iPad-based version of the Addenbrooke's Cognitive Examination-III ' Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring , vol 10 , pp. 182-187 . DOI: 10.1016/j.dadm.2017.12.003
Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring
© 2017 Published by Elsevier Inc. on behalf of the Alzheimer’s Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
The authors would like to acknowledge the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care in the South West Peninsula (PenCLAHRC) and Clinical Trials Methods in Neurodegenerative Diseases (Programme Grant RP-PG-0707-10124).
Items in the St Andrews Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.